MEVNARIA
associated with 501 other trademarks
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious,...

Words that describe this trademark:

central nervous system  nervous system endocrine  system endocrine  pharmaceutical preparations  treatment  autoimmune  preparations  cardiovascular  endocrine  gastrointestinal 

Serial Number:

90584360

Mark:

MEVNARIA

Status:

Abandoned-No Statement of Use filed

Status Date:

12-25-2023

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

09-28-2021

Mark Drawing Status:

Standart Character Mark

Abandon Date:

12-25-2023

Business Name:

PFIZER INC.

Correspondent Name:

Recent Trademark filings by this company